Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

46 Results Found

AHA, others file amicus briefs opposing major drug companies’ 340B rebate models

The AHA has filed a number of friend-of-the-court briefs in cases before the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject drug companies’ proposed 340B rebate models in separate lawsuits brought by a number of drug companies to bar the agency from doing so.

AHA, others file amicus brief opposing J&J 340B rebate model

The AHA Feb. 28 filed a friend-of-the-court brief (https://www.aha.org/amicus-brief/2025-02-28-aha-others-file-amicus-brief-opposing-jj-340b-rebate-model) in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the agency from doing so.

Washington update panel discusses legislative priorities for rural health care

AHA President and CEO Rick Pollack joined AHA’s Chad Golder, senior vice president and general counsel, Travis Robey, vice president of political affairs, and Shannon Wu, director of payment policy, for a discussion on the ever-shifting landscape of health care affairs on Capitol Hill.

HRSA directs Sanofi to cease implementing unapproved 340B rebate proposal 

The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate proposal immediately and to inform HRSA of its plans no later than Dec. 20 in order to provide adequate notice to covered entities.

Research finds drug prices increased without adding new clinical benefits

The net prices of five drugs included in a new study from the Institute for Clinical and Ec

AHA files brief to defend ruling in favor of Mississippi’s 340B contract pharmacy law

The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B contract pharmacy law.

J&J sues government over 340B proposal; AHA says J&J's legal arguments 'completely meritless' 

Johnson & Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit its implementation. 

AHA files amicus brief defending Kansas law related to 340B contract pharmacy arrangements 

The AHA Nov. 7 filed a friend-of-the-court brief in the U.S. District Court for the District of Kansas in defense of the state's law protecting against deceptive acts or practices related to 340B pricing for contract pharmacy arrangements.

AHA files amicus brief in Minnesota defending its 340B contract pharmacy law

The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.